Pivotal starts enrolment in a phase II clinical trial in patients with Von Hippel-Lindau (VHL) disease developing renal cell cancer
New collaboration aims to further accelerate the delivery of novel treatments for difficult-to-treat cancers
Pivotal has enrolled the first patients in a recently awarded new phase II trial in...